M

Mereo BioPharma Group plc
D

MREO

2.17000
USD
-0.09
(-3.77%)
مغلق
حجم التداول
48,458
الربح لكل سهم
-0
العائد الربحي
-
P/E
-9
حجم السوق
345,315,791
أصول ذات صلة الأخبار المقالات

العنوان: Mereo BioPharma Group plc

القطاع: Healthcare
الصناعة: Biotechnology
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its tworare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).